InsidersTradesSigma
Discover the full directors' dealings record of 삼진제약, a listed equity based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 삼진제약 has logged 2 reports. Market capitalisation: €242.1bn. The latest transaction was reported on 2 June 2026 (Other). Among the most active insiders: 최승주. All data is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.